Clinical Trials Browser

Carcinoma in Situ × dodecyl maltoside × 1 year × Clear all

NCT07283835 2026-04-23

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

NCT04452591 2026-03-16

BOND-003

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ